Literature DB >> 27666444

Results of common femoral artery thromboendarterectomy evaluation of a traditional surgical management in the endovascular era.

Carola Marie Wieker1, Eva Schönefeld2, Nani Osada2, Christina Lührs2, Roland Beneking2, Giovanni Torsello2, Dittmar Böckler3.   

Abstract

OBJECTIVE: The aim of this study was to investigate the long-term outcome of common femoral artery thromboendarterectomy in patients with peripheral arterial occlusive disease.
METHODS: The study retrospectively evaluated 713 vessels in 655 patients (75% male; mean age, 69.4 ± 9.5 years) who underwent common femoral thromboendarterectomy from January 2006 until May 2012 in two high-volume vascular centers. Critical limb ischemia was present in 221 patients, and intermittent claudication was present in 434. Three patent tibial arteries, described as runoff vessels, were available in 33% of the cohort, two were present in 28.3%, one runoff vessel was present in 23.4%, and 15.2% (n = 102) showed no runoff option. Hybrid procedures were used to treat 255 limbs (35.8%). The primary end point was primary patency (PP). Secondary patency (SP), limb salvage, and survival were the secondary end points.
RESULTS: Survival rates were 93.9%, 83.0%, 74.1%, and 60.1% at 1, 3, 5, and 7 years, respectively. PP was 78.5% and SP was 89.1% at 7 years. Patency rates were 97.3% (PP) and 97.8% (SP) at 6 months and 90.2% (PP) and 98.3% (SP) at 3 years, respectively, with 76 target lesion revascularizations. No significant difference was demonstrated for PP rates stratified for nonhybrid procedures and hybrid procedures (78.1% vs 78.6%; P = .22) and for critical limb ischemia vs intermittent claudication (76.3% vs 79.4%; P = .20) at 7 years. The mean ± standard deviation ankle-brachial index increased from 0.46 ± 0.3 preoperatively to 0.81 ± 0.2 postoperatively and to 0.77 ± 0.3 at 7 years (P < .001). A total of 20 major amputations were performed, achieving a limb salvage rate of 92.6%. Procedure-related complications occurred in 11.5% during 7 years of follow-up.
CONCLUSIONS: Open surgery for common femoral artery stenosis is safe and effective in the long-term. Endovascular therapy will need to compete with these excellent results.
Copyright © 2016 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27666444     DOI: 10.1016/j.jvs.2016.04.036

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  7 in total

1.  Axillobifemoral Bypasses: Reappraisal of an Extra-Anatomic Bypass by Analysis of Results and Prognostic Factors.

Authors:  D Dickas; F Verrel; J Kalff; A Koscielny
Journal:  World J Surg       Date:  2018-01       Impact factor: 3.352

2.  Evaluation of Stent Angioplasty in the Treatment of Arteriosclerotic Lesions of the Common Femoral Artery.

Authors:  Tanja Böhme; Thomas Zeller; Mohamed Abboud; Ulrich Beschorner; Elias Noory
Journal:  J Clin Med       Date:  2022-05-10       Impact factor: 4.964

3.  Systematic Review and Proportional Meta-Analysis of Endarterectomy and Endovascular Therapy with Routine or Selective Stenting for Common Femoral Artery Atherosclerotic Disease.

Authors:  Khalid Hamid Changal; Mubbasher Ameer Syed; Tawseef Dar; Muhammad Asif Mangi; Mujeeb Abdul Sheikh
Journal:  J Interv Cardiol       Date:  2019-04-14       Impact factor: 2.279

4.  Extracellular Matrix Patches for Endarterectomy Repair.

Authors:  Keith B Allen; Joshua D Adams; Stephen F Badylak; H Edward Garrett; Nicolas J Mouawad; Steven W Oweida; Manesh Parikshak; Parvez K Sultan
Journal:  Front Cardiovasc Med       Date:  2021-02-11

5.  A Case of Isolated Infragenicular Arterial Lesions Successfully Treated with Open Endarterectomy.

Authors:  Hiroko Okuda; Shinsuke Kikuchi; Atsuhiro Koya; Hidehiro Takei; Nobuyoshi Azuma
Journal:  Ann Vasc Dis       Date:  2021-03-25

Review 6.  Comparative Analysis of Endovascular Intervention and Endarterectomy in Patients with Femoral Artery Disease: A Systematic Review and Meta-Analysis.

Authors:  Nidhruv Ravikumar; Gopika Sreejith; Sharon Hiu Ching Law; Prakhar Anand; Noah Varghese; Samrin Kagdi; Navneet Kang; Mohamed Nashnoush; Sihat Salam; Ibsen Ongidi
Journal:  Hematol Rep       Date:  2022-06-01

Review 7.  An Overview of the Treatment of Symptomatic Common Femoral Artery Lesions with a Focus on Endovascular Therapy.

Authors:  Nicolas W Shammas; Amanda Abi Doumet; Rusina Karia; Rommy Khalafallah
Journal:  Vasc Health Risk Manag       Date:  2020-02-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.